Health care utilization and costs following amplified versus non-amplified molecular probe testing for symptomatic patients with suspected vulvovaginitis: a US commercial payer population

Health care utilization and costs following amplified versus non-amplified molecular probe testing for symptomatic patients with suspected vulvovaginitis: a US commercial payer population

Stacey J Ackerman,1 Tyler Knight,2 Peter M Wahl,2 Charles P Cartwright3 1Covance Market Access Services Inc., San Diego, CA, USA; 2Covance Market Access Services Inc., Gaithersburg, MD, USA; 3Center for Esoteric Testing, Laboratory Corporation of America Holdings, Burlington, NC, USA Background: Vul...

Full description

Bibliographic Details
Main Authors: Ackerman SJ, Knight T, Wahl PM, Cartwright CP
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
vulvovaginitis
preterm labor/delivery
amplified molecular probe testing
propensity-score matching
healthcare utilization
costs
Online Access:https://www.dovepress.com/health-care-utilization-and-costs-following-amplified-versus-non-ampli-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/health-care-utilization-and-costs-following-amplified-versus-non-ampli-peer-reviewed-article-CEOR

Similar Items